Pressmeddelande -
Profundus AB is moving to Astra Zeneca BioVentureHub
..............................................................
GU Ventures sprider nyheter och information kring verksamheten, sina bolag, samt alumnibolag
resterande pressmeddelande följer på engelska:
..............................................................
Profundus, pioneers in eye diagnostics with high resolution retina imaging, is now moving from GU Ventures to Astra Zeneca BioVentureHub. The hub is in the middle of the Astra Zeneca building in Mölndal Gothenburg and is an open innovation eco system where growing life science companies and researchers are in the same place for better cooperation.
Profundus is now in the process of producing two instruments for customers based on their unique research system. Recruiting and moving to new facilities are two important steps on the journey towards building a Swedish MedTech company. On the 1st of September the company will move from GU Ventures to Astra Zeneca BioVentureHub. Profundus will rent office and lab and this will give great possibilities to further optimize the system together with the Founders.
”It is great to become part of Astra Zeneca BioVentureHub and the very exciting and dynamic place close to both GoCo and world leading researchers at Sahlgrenska Academy in Sahlgrenska University Hospital Mölndal” says Åsa Lindström CEO at Profundus AB.
GU Venture´s Business Coach Elisabeth Gustafsson, Profundus’ Chairman of the board agrees;
”It is good that Profundus now takes another step towards building a company offering a new, unique and much needed technique within eye diagnostics.”
About Profundus
Profundus is a unique innovative start-up pioneering eye diagnostics to meet real needs of high-resolution retina imaging for clinical use. The company was founded by four researchers combining eye research, at the University of Gothenburg and astronomy at Lund University. The result is a new system to image single cells and the smallest capillaries in the retina. Read more at: https://www.profundusimaging.c...
About AstraZeneca BioVentureHub
AstraZeneca established the BioVentureHubin 2014 as an open innovation ecosystem to further strengthen competitiveness and dynamism in the life science industry.The BioVentureHub is based on an innovative public-private-partnership model and is located at the heart of AstraZeneca Gothenburg. It gives emerging life science companies and academic groups a unique opportunity to co-locate with and tap into the power of AstraZeneca’s world-class scientists and state of the art lab facilities and infrastructure, and with each other.
![](https://resources.mynewsdesk.com/image/upload/t_limit_1000/whhknyom0fb4wunsi80b.jpg)
Ämnen
Kategorier
Regioner
About GU Ventures AB
GU Ventures builds businesses out of groundbreaking ideas that help shape a better tomorrow and is top-ranked by UBI Global Index as one of the world's 20 leading university-run incubators. We finance and develop new innovative business ideas with connections to the University of Gothenburg, which is one of northern Europe's largest universities. Our mission is commercialize the innovations, which leads to the utilization of research and skills, renewal of the business community, job creation and sustainable growth. Our passionate team of company builders, financial experts, IP and legal talent are dedicated supporters of our companies and ensure their successes. Since our starting point in 1995, GU Ventures has developed over 200 new business ideas of which 130 are in business today and of which 14 are listed. Our portfolio consists of 70 holdings and some projects. In the latest survey, 87% of companies match the global sustainability goals set by the UN. GU Ventures is wholly owned by the Swedish state and managed by the University of Gothenburg. Feel free to read more at: www.guventures.com.